Research and development of transfer factors in the company AUMED, a.s.

AUMED, a.s. focuses on one of its research and development activities, supported by grants, to the area of transfer factors intended for human therapy.

WHAT ARE THE TRANSFER FACTORS?

Transfer factors were discovered and described by Dr. Henry Sherwood Lawrence in the late 1940s. It is still an inaccurately defined mixture of many biologically active molecules carrying immunity information. They represent a unique type of messenger used for cell-to-cell communication in the immune system.

The essence of the efficiency of transfer factors lies in the transfer of distinct cell-mediated immunity from an immuno-sufficient donor to a deficient recipient. Transfer factors have been used successfully over the past quarter of a century for treating viral, parasitic, and fungal infections, as well as immunodeficiencies, neoplasias, allergies and autoimmune diseases. Moreover, case reports in cancer treatment have been published.

WHY RESEARCH IN THIS AREA?

The development of legislation related to pharmaceutical issues generally puts increasing emphasis on the safety and efficacy of medicines. The research activities of transfer factors in AUMED, a.s. therefore focus on modernization of their preparation technology, more precise identification of the mechanism of their effects, development of more sophisticated procedures of their testing and innovation of their pharmaceutical form.